The CGTLive™ Ophthalmology specialty topic page includes the most recent clinical care news related to the development of cell therapies, gene therapies, and engineered and regenerative medicines for disorders and diseases of the eye. It also contains video interviews with key opinion leaders in the field of ophthalmology discussing related FDA actions, clinical guideline updates, and clinical trial findings in the field of gene and cell therapy for ophthalmic conditions.
December 4th 2024
Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.
Reexamining the Outcome Measures Used in Ophthalmic Gene Therapy Trials
May 15th 2023Bart P. Leroy, MD, PhD, head of the Department of Ophthalmology at the Center for Medical Genetics of Ghent University Hospital, discussed the need to reevaluate the goal posts used to determine whether gene therapies for eye indications come to market.
Arshad Khanani, MD, on 4D-150’s Ability to Address Treatment Burden in Wet AMD
May 9th 2023The director of clinical research at Sierra Eye Associates discussed the latest results from a clinical trial evaluating 4D Molecular Therapeutics’ gene therapy, 4D-150, that were presented at ARVO’s 2023 conference.